Mitsui Chemicals, Inc.

4183.T
Specialty Chemicals
2026/08/21 Updated
Market Cap: $4.8B (¥763.9B)
Stock Price: $13.29 (¥2,113)
Exchange Rate: 1 USD = ¥158.98

First Quarter of the Fiscal Year Ending March 2027 IFRS Consolidated Financial Results (Unaudited) [IFRS] (Consolidated)

The consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 4,600,046 million yen (YoY +10.8%), core operating income of 501 million yen (YoY +88.4%), operating income of 484 million yen (YoY +279.8%), and net income attributable to owners of the parent of 321 million yen (YoY +4,302.3%). All segments—Life & Health Care Solutions, Mobility Solutions, ICT Solutions, and Basic & Green Materials—posted higher net sales and earnings. For the full-year outlook, pretax profit is expected at 61,000 million yen and net income at 74,000 million yen, with the per-share amount including the impact of share split estimated at ¥94.05 (accumulated for the first half). No changes to the dividend forecast.

Importance:
Page Updated: August 5, 2026
IR Disclosure Date: August 5, 2026

Key Figures

  • Net sales: 4,600,046百万円(YoY +10.8%)
  • Core operating income: 50,129百万円( YoY +88.4%)
  • Net income attributable to owners of the parent for the quarter: 32,093百万円(YoY +4,302.3%)

AI要約

Overview of results

The consolidated net sales for the first quarter were 4,600,046 million yen, up 10.8% year over year, and core operating income was 501 million yen, up 88.4%. Improvements were supported by higher inventory gains from raw material price increases and foreign exchange effects. Operating income rose sharply to 484 million yen. All four segments—Life & Health Care Solutions, Mobility Solutions, ICT Solutions, and Basic & Green Materials—achieved higher net sales and earnings. For the second quarter onward, the outlook remains aligned with the initial full-year forecast.

Financial position and cash flows

At period-end, total assets were 2,262,306 million yen, total liabilities 1,264,721 million yen, and equity attributable to owners of the parent 873,247 million yen. Cash and cash equivalents stood at 2,178 million yen. Operating cash flow is expected to be around 1,400 million yen. Cash flow from financing activities was a positive 471 million yen, while investing activities were a outflow of 292 million yen. Note the improvement in capital efficiency, including increased equity method investees’ profits.

Net Sales Trend

Core Operating Income Trend

Segment Net Sales Share (Q1)

Segment Core Operating Profit

Comparison of Guidance and Actuals

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Mitsui Chemicals, Incorporated

Company overview · Stock price · Financial data · All IR

View company page →